Insider Trading History of Keating Laurie


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Keating Laurie since year 2005. The trader's CIK number is 1620743. At the time of the last reporting, Keating Laurie was the EVP, Chief Legal Officer of Alnylam Pharmaceuticals, Inc. . (stock ticker symbol ALNY). See this page for all insider trading activities at Alnylam Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Keating Laurie since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-10 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,000 77.40 774,000
2020-02-10 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,000 129.00 1,290,000
2020-01-29 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 6,337 77.40 490,483
2020-01-29 ALNY Alnylam Pharmaceuticals, Inc. Sale 6,337 119.00 754,103
2020-01-27 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 34,374 42.22 1,451,270
2020-01-27 ALNY Alnylam Pharmaceuticals, Inc. Sale 41,037 118.00 4,842,366
2018-06-20 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 1,563 42.22 65,989
2018-06-20 ALNY Alnylam Pharmaceuticals, Inc. Sale 1,563 105.04 164,177
2018-03-20 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 1,562 42.22 65,947
2018-03-20 ALNY Alnylam Pharmaceuticals, Inc. Sale 1,562 149.68 233,797
2018-03-12 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,000 77.40 774,000
2018-03-13 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 10,000 77.40 774,000
2018-03-12 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,000 140.00 1,400,000
2018-03-13 ALNY Alnylam Pharmaceuticals, Inc. Sale 10,000 150.00 1,500,000
2017-12-29 ALKS Alnylam Pharmaceuticals, Inc. Option Ex 3,000 77.40 232,200
2017-12-20 ALKS Alnylam Pharmaceuticals, Inc. Sale 6,249 121.70 760,484
2017-12-20 ALKS Alnylam Pharmaceuticals, Inc. Option Ex 6,249 42.22 263,832
2017-12-01 ALNY Alnylam Pharmaceuticals, Inc. Option Ex 30,000 77.40 2,322,000
2017-12-01 ALNY Alnylam Pharmaceuticals, Inc. Sale 30,000 135.46 4,063,859
2017-05-30 ALNY Alnylam Pharmaceuticals, Inc. Buy 11,500 65.35 751,502

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Keating Laurie (EVP, Chief Legal Officer of Alnylam Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month